Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A R Mire-Sluis

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Developments in Biologicals|June 25, 2002
Setting specifications for potency assays--basic principlesA R Mire-Sluis
Developments in Biological Standardization|August 27, 1999
Analytical characterisation of cytokines and growth factorsA R Mire-Sluis
Developments in Biological Standardization|November 24, 1999
The development of non-animal-based bioassays for cytokines and growth factorsA R Mire-Sluis
Pharmaceutical Research|October 31, 2001
Progress in the use of biological assays during the development of biotechnology productsA R Mire-Sluis
Developments in Biologicals|November 19, 2002
Challenges with current technology for the detection, measurement and characterization of antibodies against biological therapeuticsA R Mire-Sluis
Developments in Biological Standardization|January 1, 2000
Cytokine and growth factor standardization: the need for research to answer modern issuesA R Mire-Sluis
Trends in Biotechnology|July 17, 1999
Cytokines: from technology to therapeuticsA R Mire-Sluis
The Journal of Biological Chemistry|September 25, 1991
Interleukin-4 proliferative signal transduction involves the activation of a tyrosine-specific phosphatase and the dephosphorylation of an 80-kDa proteinA R Mire-Sluis, R Thorpe
Developments in Biologicals|May 24, 2003
An overview of scientific and regulatory issues for the immunogenicity of biological productsP Chamberlain, A R Mire-Sluis
Journal of Immunological Methods|June 9, 1998
Laboratory protocols for the quantitation of cytokines by bioassay using cytokine responsive cell linesA R Mire-Sluis, R Thorpe
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Developments in Biologicals|June 25, 2002
Setting specifications for potency assays--basic principlesA R Mire-Sluis
Developments in Biological Standardization|August 27, 1999
Analytical characterisation of cytokines and growth factorsA R Mire-Sluis
Developments in Biological Standardization|November 24, 1999
The development of non-animal-based bioassays for cytokines and growth factorsA R Mire-Sluis
Pharmaceutical Research|October 31, 2001
Progress in the use of biological assays during the development of biotechnology productsA R Mire-Sluis
Developments in Biologicals|November 19, 2002
Challenges with current technology for the detection, measurement and characterization of antibodies against biological therapeuticsA R Mire-Sluis
Developments in Biological Standardization|January 1, 2000
Cytokine and growth factor standardization: the need for research to answer modern issuesA R Mire-Sluis
Trends in Biotechnology|July 17, 1999
Cytokines: from technology to therapeuticsA R Mire-Sluis
The Journal of Biological Chemistry|September 25, 1991
Interleukin-4 proliferative signal transduction involves the activation of a tyrosine-specific phosphatase and the dephosphorylation of an 80-kDa proteinA R Mire-Sluis, R Thorpe
Developments in Biologicals|May 24, 2003
An overview of scientific and regulatory issues for the immunogenicity of biological productsP Chamberlain, A R Mire-Sluis
Journal of Immunological Methods|June 9, 1998
Laboratory protocols for the quantitation of cytokines by bioassay using cytokine responsive cell linesA R Mire-Sluis, R Thorpe
Pageof 5